Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
GHRS
#2436
GH Research PLC Ordinary Shares
16.770
0
USD
+2.63%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.63%
Aylık Değişim
+11.43%
6 aylık değişim
+18.43%
Yıllık Değişim
+18.43%
Önceki Kapanış
16.340
0
Open
16.770
0
Bid
Ask
Low
16.770
0
High
16.770
0
Hacim
15
Piyasalar
ABD Borsası
Sağlık Hizmetleri
GHRS
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
52.02 M
52.02 M
52.03 M
52.03 M
62.03 M
218.11 M
Valuation ratios
Enterprise value
936.87 M
337.09 M
199.93 M
263.41 M
541.52 M
1.93 B
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.09
0.16
0.21
0.17
—
Return on equity %
0.03
0.09
0.16
0.22
0.17
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
101.8
37.07
24.49
17.23
34.13
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Haberler
Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?
GH Research depresyon tedavisi için faz 2b sonuçlarını yayınladı
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3
Guggenheim, GH Research için hisse hedefini 34 dolara yükseltti
Guggenheim raises GH Research stock price target to $34 on trial data
Needham, GH Research için hedef fiyatı 32 dolara yükseltti
Needham raises GH Research stock price target to $32 on phase 3 plans
Citizens, GH Research’ün hisse hedefini yükseltti
Citizens raises GH Research stock price target on phase 3 progress
GH Research depresyon tedavisi için Faz 2b deneme sonuçlarını açıkladı
GH Research reports Phase 2b trial results for depression treatment
GH Research hisse fiyat hedefi RBC Capital tarafından 33 dolardan 40 dolara yükseltildi